Physician

Hobart W Walling, M.D.

According to 2025 Medicare claims, Hobart Walling, M.D. (NPI: 1477506814) practices dermatology in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY OF IOWA, PLC (NPI: 1104451749; TIN: 844900614) and primary practice location at 52241-1774.

Walling's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 897 traditional Medicare patients, billed 5,861 HCPCS/CPT codes, and received $407,392 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 649 prescription claims across 316 beneficiaries totaling $102,048 in drug costs, led by Fluorouracil (Fluorouracil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $47,994 to $102,048. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$204K$407K2015 Medicare payment: $347,203 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $279,216 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $272,135 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $312,212 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $295,896 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $277,366 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $326,067 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $397,431 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $357,058 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $407,392 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158585,167$347,203
20169105,132$279,216
20179204,894$272,135
20188664,780$312,212
20198284,377$295,896
20207124,153$277,366
20218134,653$326,067
20228475,602$397,431
20238705,662$357,058
20248975,861$407,392

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$81K$162K2015 Drug cost: $47,994 (USD; Tot_Drug_Cst)2016 Drug cost: $51,016 (USD; Tot_Drug_Cst)2017 Drug cost: $36,391 (USD; Tot_Drug_Cst)2018 Drug cost: $26,282 (USD; Tot_Drug_Cst)2019 Drug cost: $99,545 (USD; Tot_Drug_Cst)2020 Drug cost: $129,107 (USD; Tot_Drug_Cst)2021 Drug cost: $121,203 (USD; Tot_Drug_Cst)2022 Drug cost: $113,064 (USD; Tot_Drug_Cst)2023 Drug cost: $162,196 (USD; Tot_Drug_Cst)2024 Drug cost: $102,048 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015232547$47,994
2016261587$51,016
2017236501$36,391
2018227443$26,282
2019196352$99,545
2020199381$129,107
2021228467$121,203
2022260491$113,064
2023255483$162,196
2024316649$102,048

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth410542$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more563702$59
11103Biopsy of related skin growth, each additional growth245435$37
17000Destruction of precancer skin growth, 1 growth398542$33
17003Destruction of precancer skin growth, 2-14 growths2881,694$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil421,158$3,014
KetoconazoleKetoconazole1113,176$1,680
TretinoinTretinoin22645$1,517
MetronidazoleMetronidazole16470$728
ImiquimodImiquimod461,675$720

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Hobart W. Walling, M.D.?

Tedicare shows public-source Medicare data for Hobart W. Walling, M.D. (NPI 1477506814), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hobart W. Walling, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hobart W. Walling, M.D.?

Hobart W. Walling, M.D. is linked to EPIPHANY DERMATOLOGY OF IOWA, PLC (billing NPI 1104451749) in the available physician profile data.

Does Hobart W. Walling, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.